Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

• Prif Awduron: Łukasz Pyka MD, PhD (Awdur), Bartosz Hudzik MD, PhD (Awdur), Stanisław Bartuś MD, PhD (Awdur), Paweł Buszman MD, PhD (Awdur), Marek Gierlotka MD, PhD (Awdur), Wojciech Wojakowski MD, PhD (Awdur), Jarosław Hiczkiewicz MD, PhD (Awdur), Andrzej Kleinrok MD, PhD (Awdur), Michał Skrzypek MD, PhD (Awdur), Wiktor Kuliczkowski MD, PhD (Awdur), Mariusz Gąsior MD, PhD (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: SAGE Publishing, 2023-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Introduction The prevalence of atrial fibrillation (AF) in acute coronary syndrome (ACS) patients is increasing. Data on outcomes of anticoagulation in ACS patients with AF are lacking. Objectives The aim of our study was to investigate the prevalence of stroke, myocardial infarction, bleeding compl...